Cambridge’s Next Biotech Beacon Gains Altitude
Led locally by Bill Kane, Blackstone-owned BioMed Realty is building one of Cambridge’s most notable new projects, the 585 Kendall tower leased to Takeda Pharmaceuticals.
New Factors Give Occupiers Even Stronger Hand in Lab Market
The life sciences and lab market across the Boston metro area has been in a state of flux for some time, but a new factors have added extra pressure on landlords and owners.
AI Biotech Researchers Relocate to Cambridge
A biotech company that’s received over $400 million from investors for its artificial intelligence-based research opens a new headquarters in Cambridge this week in a relocation from New York City.
